Multidimensional Analyses of Long-Term Clinical Courses of Asthma and Chronic Obstructive Pulmonary Disease
Authors:
Open Access
- 1 January 2010
- journal article
- review article
- Published by Japanese Society of Allergology in Allergology International
- Vol. 59 (3) , 257-265
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory disorders involving obstructive airway defects. There have been many discussions on their similarities and differences. Although airflow limitation expressed as forced expiratory volume in one second (FEV(1)) has been considered to be the main diagnostic assessment in both diseases, it does not reflect the functional impairment imparted to the patients by these diseases. Therefore, multidimensional approaches using multiple measurements in assessing disease control or severity have been recommended, and multiple endpoints in addition to FEV(1) have been set recently in clinical trials so as not to miss the overall effects. In particular, as improving symptoms and health status as well as pulmonary function are important goals in the management of asthma and COPD, some patient-reported measurements such as health-related quality of life or dyspnea should be included. Nonetheless, there have been few reviews on the long-term clinical course comparing asthma and COPD as predicted by measurements other than airflow limitation. Here, we therefore analyzed and compared longitudinal changes in both physiological measurements and patient-reported measurements in asthma and COPD. Although both diseases showed similar long-term progressive airflow limitation similarly despite guideline-based therapies, disease progression was different in asthma and COPD. In asthma, patient-reported assessments of health status, disability and psychological status remained clinically stable over time, in contrast to the significant deterioration of these parameters in COPD. Thus, because a single measurement of airflow limitation is insufficient to monitor these diseases, multidimensional analyses are important not only for disease control but also for understanding disease progression in asthma and COPD.Keywords
This publication has 65 references indexed in Scilit:
- Radiological Approach to Asthma and COPD-The Role of Computed TomographyAllergology International, 2009
- Physiological Differences and Similarities in Asthma and COPD—Based on Respiratory Function Testing—Allergology International, 2009
- Genetic Backgrounds of Asthma and COPDAllergology International, 2009
- Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and controlThe Lancet, 2008
- Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammationJournal of Allergy and Clinical Immunology, 2007
- Airway remodeling contributes to the progressive loss of lung function in asthma: An overviewJournal of Allergy and Clinical Immunology, 2005
- Local and Systemic Inflammation in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Longitudinal changes in airflow limitation and airway hyperresponsiveness in patients with stable asthmaAnnals of Allergy, Asthma & Immunology, 2002
- Health status measurement in chronic obstructive pulmonary diseaseThorax, 2001
- Health-related quality of life in asthmaCurrent Opinion in Pulmonary Medicine, 1999